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Background: In the Italian context, evolving toward the abandonment of compulsory vaccination, the 
maintenance of adequate levels of coverage appears as essential. The promotion of a good vaccination 
knowledge, supported by strong scientific evidence, and the collaboration of all the involved stakeholders, 
appears hence fundamental. The aim of this survey was to understand why vaccination is not appreciated 
for its real value by different stakeholders.
MeThods: In collaboration with other Italian universities and health districts, in summer 2011 we submit-
ted a survey of 17 questions to a convenience sample of Italian Medical doctors, Policy Makers and general 
Population. The main questions analyzed the importance of vaccination for health, actions to attain vac-
cination value and consequences of a free choice policy. 
resulTs: of the 173 stakeholders interviewed, 78% of Medical doctors, 82% Policy Makers and 46% 
general Population believe that vaccination is important for health. The most important actions suggested 
for strengthening vaccination were information about its efficacy and safety and studies on its impact on 
Public health, according to most of general Population and of Medical doctors and Policy Makers, respec-
tively. according to 60.4% Medical doctors, 72.8% Policy Makers and 56.3% general Population the aboli-
tion of compulsory vaccination would lead to a reduction of vaccinees in all the Italian regions. 
conclusIons: our study confirms the need for a thorough “education in vaccination”. among stakehold-
ers there are still doubts that hinder the decision process about vaccination policies and programmes. on 
the other hand, a call for an “alliance” for promoting and implementing vaccination to its full potential 
would be favoured, as sustained by a right understanding and attitude towards vaccines. 
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IntroductIon
Vaccination is one of the most efficient and 
reliable provision of Public Health for the primary 
prevention of infectious diseases and beneficial not 
only for individuals subject to this practice, but pro-
tective on the entire community, giving immunity 
indirectly to non-vaccinated people by the so-called 
phenomenon of “herd immunity” (1).
The discovery and introduction of vaccines 
as immunoprophylaxis had a profound influence 
on the epidemiology of infectious diseases and 
vaccines have emerged as a major tool for reduc-
ing mortality and morbidity. The use of vaccina-
tion has led to results often sensational, such as 
the elimination of smallpox, declared eradicated 
by the World Health Organization (WHO) on May 
8th 1980 (2). 
The decrease of the incidence of many infec-
tious diseases was in fact significantly correlated 
4 8
I T A L I A N   J O U R N A L   O F   P U B L I C   H E A L T H
IJPH - 2012, Volume 9, Number 1
T H E  vA L U E  O F  vA C C I N AT I O N
with increased levels of vaccine coverage, and 
the scientific literature leaves no doubt about the 
effectiveness of vaccines in general and their usu-
ally high cost/effectiveness (3-6). 
However, one of the greatest obstacles to 
investment in vaccines is that, unlike therapeutic 
drugs whose effectiveness is shown in the short-
medium term and on the single individual, the 
beneficial impact of vaccination on health can 
only be seen in the long term and on large cohorts 
of populations (7).
In addition, more and more information is 
provided for misleading the public about the inef-
fectiveness and lack of safety of vaccines and this 
information, even if not adequately supported 
by scientific evidence, are conveyed through the 
new means of communication, especially inter-
net, spreading everywhere without any control.
Moreover, some scientific studies, often 
fraudulent and devoid of scientific validity, con-
tribute to cast doubts on the safety of vaccine: 
this is the case, recently ended, of the British gas-
troenterologist Wakefield, who published in 1998 
the results of his study in which he hypothesized a 
correlation between the trivalent measles-mumps-
rubella vaccine (MMRV), inflammatory bowel 
disease (IBD) and autism. In this story the media 
played a crucial role: newspapers, magazines, 
television and radio in many countries reported 
and amplified the news, with important repercus-
sions on public opinion and public health conse-
quences. There was a decrease in the number of 
vaccinations in the USA, Great Britain and other 
parts of Europe, and a subsequent sharp increase 
in cases of measles in these countries. In 2010, 
the General Medical Council, the British equiva-
lent of the Italian Ordine dei Medici, recognized 
Dr. Wakefield guilty of conducting research with 
methods ethically questionable and scientifically 
invalid, and the prestigious scientific journal 
Lancet withdrew the article published (8). 
Episodes like this contribute to the creation 
of myths about vaccinations, beliefs fuelled by 
misinformation that, although totally empty of 
scientific foundation, help to generate a climate of 
distrust among general population and, paradoxi-
cally, even among health professionals, leading to 
dangerous consequences on individual and collec-
tive health. The attitude of distrust has been fur-
ther revealed during the recent A/H1N1 pandemic 
flu, when health officials expressed a very poor 
adhesion to vaccination and resistance to promo-
tion of vaccination campaigns (9-11). 
In the Italian context, which gradually evolves 
toward the abandonment of compulsory vaccina-
tion, the maintenance of adequate levels of cover-
age appears as essential and to achieve this goal is 
fundamental the promotion of a good vaccination 
knowledge, supported by strong scientific evi-
dence, and the empowerment and collaboration 
of all the involved stakeholders, from politicians 
to general population. 
In this context, we conducted a knowledge, 
attitudes and behaviour (KAB) survey in order to 
find out which is the real value of vaccination for 
Italian health care professionals, policy makers 
and general population. 
MaterIals and Methods
In collaboration with other Italian Universities 
(Turin, Milan, Udine, Florence, Rome Tor Vergata, 
Second University of Naples, Catanzaro, Palermo) 
and Health Districts (Bolzano, Perugia, Potenza, 
Taranto), from August to October 2011 we sub-
mitted this pilot survey, composed by 17 multiple 
choice questions, to a convenience sample of 
Medical Doctors (MD), Policy Makers (PM) and 
General Population (GP) of Northern, Central and 
Southern Italy. MD comprised academic profes-
sors, researchers and residents. The questionnaire 
was designed by one of the Authors and was 
anonymous. It was composed of different parts 
accounting for:
 knowledge about vaccination in general, 
including its efficacy and safety (2 questions);
 attitudes towards vaccination as an important 
mean of prevention and ways of promoting it 
(3 questions);
 importance of vaccination for health and 
impact on health structures (number of 
entries to Emergency Department, hospital-
izations, etc.) (1 question); 
 the anti-vaccination movements (AVM) (2 
questions); 
 personal and institutional behaviour towards 
vaccination (4 questions); 
 most important categories to be involved in 
more effective vaccine policies and initiatives 
to promote vaccination (2 question); 
 major obstacles to the diffusion of vaccina-
tion (1 question); 
 consequences of the potential abolition of 
compulsoriness for paediatric vaccinations in 
Italy (1 question). 
Questionnaires were delivered by email or 
personally and were asked to hand it back to 
Università Cattolica in Rome by e-mail or by ordi-
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nary mail. Everyone who filled in the question-
naire was also asked to sign the authorisation of 
anonymous data processing and use, which is 
legally mandatory in Italy.
Data were then collected in three different 
databases (MD, PM, general population) and pro-
cessed separately in order to make a descriptive 
analysis of the KAB of all the people interviewed. 
Frequencies and percentages were calculated 
for the answers given for each of the questions. 
Statistical analysis was carried out using the statis-
tical software SPSS12.0.
results
One hundred and one MDs (30% General 
Practitioners - GPs, 18% free-choice paediatricians 
- PLS, 16% academic professors, 36% researchers 
and residents in Public Health), 22 PM and 50 citi-
zens were interviewed. 
Among MD, 27.9% came from the North of 
Italy, 40.5% from the Centre and 31.6% from the 
South and Islands. PM were mainly from Northern 
Italy (40.9%), from Southern and Islands (36.4%) 
and from the Centre (22.7%), while population 
was mostly composed by southerner or islander 
(60%) and from the Centre (24%) or the North 
(16%) of the country. 
Mean age was 49.5 years for MD (Standard 
Deviation – SD: 10.4), 48.5 years for PM (SD: 9.2) 
and 44.3 years for general population (SD: 14.1). 
Vaccination was recognized as a safe and effi-
cacious mean of prevention by almost the whole 
sample (99% MD, 100% PM, 74% citizens). About 
the question regarding ways of implementation 
of prevention policies, answers given by PM were 
different compared to those of general population: 
PM would mostly offer free-of-charge vaccination 
only to risk groups (65%), while general population 
would rather invest in free universal vaccination 
(65%). However, both PM and general population 
expressed the need to be more informed about vac-
cines (65% PM, 51.1% citizens). 
Vaccination is perceived by MD as less impor-
tant than a healthy diet for their patients’ health 
(83% vs 77.8%), but as more important than 
hand washing and physical activity (64.6% and 
68.4%, respectively). By contrast, PM recognized 
the overall importance of vaccination vs the 
other abovementioned practices (81.8% vs 77.3% 
healthy diet, 54.5% hand washing and 59.1% 
physical activities), differently from general popu-
lation, 45.5% of whom considered very important 
to be vaccinated, instead of following a healthy 
diet (85.4%), washing hands (67.4%) and doing 
physical activity (63.6%). 
Many people are still not aware of the exis-
tence of AVM: in particular, this is true for 25.5% 
of MD, 40.9% of PM and 79.6% of general popu-
lation. About the importance to be vaccinated 
for health care workers (HCW), only 41.6% of 
MD answered that it is more important than 
for patients, in comparison with 56.4% and 2% 
who answered respectively that it is equally or 
less important. Different reasons were sustained 
among those who do not to trust in vaccination 
(Table 1). 
PM are the category which thought mostly 
that National government do not invest enough 
in prevention through vaccination (57.2% vs 
29% MD and vs 17% citizens), while MD and PM 
are those who mostly believe that vaccination 
may reduce the number of entries to Emergency 
Department, of medical consultations and hospi-
talizations (54% and 54.6% respectively vs 36.8% 
of general population). 
Eighty-five percent of MD believe that GPs 
and PLS are those who could have the major 
potential initiative power and ability for the pro-
motion and working-out of more efficacious vac-
cination policies, followed by media (75.8%) and 
clinicians (49%). Media are indicated by 90.9% 
of PM and by 76.1% of general population as the 
best intermediary to do it, before GPs and PLS 
(76.2% of PM), pharmaceutical industry (70.2% 
of general population), individuals and associa-
tions (68.2% of PM) and universities (65.2% of 
general population).
table 1
answers to the question “why you do not 
agree with the sentence “Vaccination giVes 
important adVantages”?”
Md (%) PM (%) gP (%)
Disease is not 
prevented
33.3 22.2 28.5
Mutant strains 26.7 22.2 14.3
Unsafety 13.3 22.2 25
Serious adverse 
events
6.7 22.2 3.6
No sufficient or 
clear information 
- 11.1 25
Other 20 0.1 3.6
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Table 2 shows the initiatives recognized by 
the sample as the most potentially efficacious for 
the adoption of vaccination policies at a national 
and regional level. 
The lack of conviction and collaboration 
among physicians was identified as one of the 
greatest obstacle to the development of more effi-
cacious vaccination policies and to a greater diffu-
sion of vaccination by 45.5% of MD, 33.3% of PM 
and 23.3% of general population. Other factors 
recognized as relevant obstacles were the scarce 
information about vaccines effectiveness and indi-
rect advantages (33% MD, 28.6% PM, 29.5% gen-
eral population) and the risk of adverse events 
(39% MD, 38.1% PM, 37.8% general population). 
Results about the opinion of MD about the 
possible effects of the elimination of compul-
soriness for paediatric vaccination in Italy are 
shown in Figure 1. 
The answers given by PM and general popu-
lation to the abovementioned question were as 
follows: reduction of the number of vaccinees all 
over Italy (72.8% PM, 56.3% general population), 
reduction of the number of vaccinees only in 
some regions (22.7% PM, 12.5% general popula-
tion), increased number of vaccinees all over Italy 
(4.2% general population), increased number of 
vaccinees only in some regions (4.5% PM), no 
rebound (12.5% general population), don’t know 
(14.5% general population). 
dIscussIon
Our survey found that MD, PM and general 
population are still not completely aware of 
the great value and potential of vaccination. 
Moreover, opinions were different for most of 
topics among the three categories examined, 
making more difficult the chance of integrat-
ing and sharing views and attitudes for the 
creation of an alliance for vaccination strate-
gies composed by the major stakeholders. 
However, all the answers given by both MD 
and PM and general population underline the 
problem of misinformation about vaccination 
and all that turns around it, from the efficacy of 
vaccines to their side effects to herd immunity. 
The misinformation appears hence diffused 
not only among general population, but also 
among HCW, those who should vouch for the 
value of vaccination. 
Firstly, it is not reassuring the fact that not 
all the MD and only 74% of general population 
recognize vaccination as a safe and efficacious 
mean of prevention. This scenario is sustained by 
what happened for A/H1N1 vaccination in Italy 
as well as in other countries, when MD showed 
a resistance to be vaccinated and to advice their 
patients to get immunized (12-14). 
table 2
initiatiVes recognized as the most 
potentially efficacious for the adoption 
of Vaccination policies at a national 
and regional leVel 
Md 
(%)
PM 
(%)
gP 
(%)
Information/documentation 
about efficacy and safety of 
vaccines
52 50 40.8
Studies about the cost 
reduction obtainable 
thanks to vaccination
29 45.5 22.9
Studies about the health 
impact of vaccination on 
general population
56.4 54.5 35.4
Clinical trials extended to a 
larger sample of individuals
39.6 27.3 24.4
Exhaustive studies of 
pharmacovigilance 
43.4 31.8 30.2
fig. 1
md opinion about the possible effects 
of the elimination of compulsoriness 
for paediatric Vaccination in italy 
 reduction of vaccinees all over Italy (60.4%)
 reduction of vaccinees only in some regions (19.8%)
 no rebounds on the number of vaccinees (12.9%)
 don't know (6.9%)
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Another important finding regards the impor-
tance of vaccination for one’s health: for MD it is 
less relevant than a healthy diet but the thing to 
be noticed is that they still do not think the hand 
washing as a primary measure for the reduction of 
transmission of diseases and for everyone’s health. 
The hand washing had just viewed an increase in 
practice among HCW and population in conjunc-
tion with the pandemic flu, maybe favoured by 
the media advertising pressure, but after that its 
high significance as preventive tool seems to be 
already forgotten (15). Similar was the opinion of 
general population, who even placed vaccination 
at the bottom of the importance among the four 
practices asked to be scored. On the contrary, 
PM seem more sensitive than MD and general 
population to the beneficial effects of vaccination 
for health, and this is relevant as could have use-
ful rebound on the allocation of money in public 
health preventive measures. At the question about 
investments in prevention policies, PM showed 
a concrete awareness of the lack of economical 
resources and so opted for giving free-of-charge 
vaccination only to risk groups. This is in contrast 
with the wish of general population, who would 
like a universal free-of-charge offer, impossible 
in a period of limited funds as the one we live in 
today. Anyway, the answer about possible ways of 
investment in prevention shared both by PM and 
general population is the need for more informa-
tion about vaccination, which is probably also 
the reason why there are still groups of popula-
tion so sceptical about this mean of prevention. 
Additionally it is probably the same scepticism 
arisen from disinformation that brought to the 
appearance of AVM, today known by three out 
of four MD, more than a half of PM and approxi-
mately 21% of general population. 
Not all the MD of our sample believed that 
getting themselves vaccinated is more important 
than to vaccinate general population: as also 
found by other Authors (16), in fact, if HCW get 
immunized, they probably do so primarily for 
their own benefit and not for the benefit to their 
patients. This is a relevant misconception about 
vaccines, that recently appeared stronger during 
the diffusion and recommendation for pandemic 
flu vaccination (17). In order to reduce this dis-
information, education should be improved, and 
organizational barriers should be bridged with 
sustainable, structural changes to allow flexible 
and workplace vaccine delivery (16, 18). The 
lack of information among general population 
also emerged in the statement that vaccination is 
able to potentially reduce the number of entries 
to Emergency Department and of physician con-
sultations, as demonstrated by the only 36.8% of 
general population agreeing with this sentence. 
Opinions of MD were shown to be different 
from those of PM and general population with 
regard to the major potential initiative power and 
ability for the promotion and working-out of more 
efficacious vaccination policies: MD were more 
trustful in GPs and PLS for this duty, while PM 
and general population looked at the media as the 
most effective tool, probably for their universal 
diffusion and the more and more current sharing 
of information through the web (19). 
About the question regarding the initiatives 
recognized as the most potentially efficacious for 
the adoption of vaccination policies at a national 
and regional level, the need for information and 
documentation about efficacy and safety of vac-
cines and for studies about the health impact 
of vaccination on general population demon-
strated again the claim for more information 
about vaccination. This fact was also confirmed 
by the answers given by all the three categories 
interviewed to the identification of the greatest 
obstacle to the development of more efficacious 
vaccination policies and to a greater diffusion of 
vaccination. Another obstacle, indicated mostly 
by MD, was the lack of conviction and collabora-
tion from physicians, showing that there is aware-
ness that opinion of MD towards vaccination is 
very disparate. In this context, future vaccination 
programmes including targeted education and 
vaccine delivery for HCW would be useful to 
cross the abovementioned obstacle (20).
When MD, PM and general population were 
asked to give an opinion about the possible effects 
of the elimination of compulsoriness for paediatric 
vaccination in Italy, the most shared thought was 
the reduction of number of vaccinees. This is not 
surprising, as in 1998 a considerable difference 
between the coverage achieved for compulsory 
(diphtheria, tetanus, polio, hepatitis B) and for 
recommended (pertussis, Hib, measles, mumps 
and rubella) vaccines has already been shown in 
Italy (21). The situation has fortunately improved 
from 2003, but there are still differences between 
one region and another, and this heterogeneous 
scenario would probably be repeated in case of an 
elimination of compulsoriness. The problem that 
should be considered by policy makers before 
opting for this decision is the one shown from the 
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results of our survey: the general lack of informa-
tion about vaccines and vaccination in general. 
Many studies demonstrated in fact that the most 
common reason for non compliance to vaccina-
tion is the refusal of parents, very often derived 
from lack of or wrong information (22-25). One 
of the possible solutions, that could open the way 
to the elimination of compulsoriness in a longer 
future as well, would be the improvement of 
immunization rates among children whose par-
ents either are open to vaccination but encounter 
barriers to obtaining vaccines or hesitate because 
of fears and concerns about safety. In order to 
achieve this goal health care professionals, health 
care organizations, and regional and national poli-
cymakers all would share great responsibility. As 
Douglas S. Diekema says in his recent article pub-
lished on New England Journal of Medicine (25), 
this solution seems to be the most effective tool to 
increase vaccine coverage, as parents who oppose 
vaccination on the basis of personal beliefs will 
probably remain opposed despite the best efforts 
of clinicians and public health experts. 
Another issue to be considered in this field 
is the lack of information. As outlined by Monti 
et al. (26), the information on influenza vaccina-
tion A/H1N1 received broad media attention dur-
ing the pandemic period. This information was 
usually correct, but sometimes it failed to show 
clear messages, especially concerning potential 
side effects. This lack of information seems to be 
the main responsible for the low uptake of vac-
cination in healthcare workers, as well as in the 
general population. We must not forget that the 
social impact of an epidemics of a given infectious 
diseases could be considerable, even more in case 
of pandemics (27). 
Finally, we have to consider that, according 
to Fletcher, also sharing of best practices from 
vaccination schedules might rationalize vaccine 
development, as well as streamline the introduc-
tion of novel vaccines into the national immuniza-
tion programs, and facilitate the evaluation of the 
impact of new vaccines not only in single Member 
States but also in Europe (28). 
In conclusion, if in assessing the value of 
vaccines different perspectives could be taken 
into account, we must recognize that, despite the 
potential availability of vaccines, according to lim-
ited economic health resources, the Governments 
will not be capable to finance all vaccines pro-
duced by drug companies. In this context it will 
be more and more important in the next future 
not only considering the emerging and re-emerg-
ing infectious diseases issue (29), but also how to 
better allocate resources, especially in the field of 
public health interventions (30).
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